Innovation driving the future of diagnostics
Advancing diagnostic technologies through research, collaboration and scientific expertise to meet emerging healthcare needs.
Shaping the future of diagnostics
From scientific discovery to real-world diagnostic solutions, we innovate through research, collaboration and technological expertise.
Scientific excellence, technological innovation, applied R&D, and collaborative partnerships enable us to develop diagnostic technologies that address emerging healthcare challenges. Through technology transfer, knowledge exchange, and continuous improvement, we transform scientific advances into solutions that create lasting value for healthcare professionals, industry partners, and patients worldwide. Technology intelligence and intellectual property management further strengthen our ability to anticipate future needs and drive sustainable innovation.
129
R&D Personnel (2024)
50
Number of PhDs
14
Patents
6.4M€
R&D investment (2024)
ISO 13485
certified QMS
89 IVDR
certified products
Resources and capabilities
Interdisciplinary teams
Facilities, laboratories and equipment
Full product lifecycle
Industry 4.0
Alliances and collaborations
Research Areas
Infectious diseases
Human genetic diseases
Oncology
Biomarkers
Advancing nucleic acid–based therapies
Infectious diseases
Committed to the creation of innovative solutions, we focus on tackling pathogens, including emerging variants, and combating antimicrobial resistance through the development of novel IVD products and advanced therapies for the treatment of infectious diseases.
Human genetic diseases
With a dedicated emphasis on personalized medicine, our efforts revolve around forging groundbreaking diagnostic solutions based on qPCR and Next Generation Sequencing techniques, coupled with the innovation of nucleic acid therapies, that redefine diagnostics and treatment approaches, ushering in a new era of precision care.
Oncology
We are dedicated to finding solutions that enhance the healthcare of cancer patients. Our approach involves conducting precise and sensitive analyses of genetic alterations linked to cancer, to improve the accuracy of diagnosis, treatment, and prognosis, tailoring medical interventions to the individual patient's unique genetic profile.
Biomarkers
We develop innovative and user-centric solutions designed to detect biomarkers with exceptional accuracy, both within hospital settings and beyond, ensuring seamless applicability in various environments.
Advancing nucleic acid–based therapies
We contribute to the evolution of cutting-edge therapeutic nucleic acids by developing novel RNA sequences (short and long RNA). We are also pushing beyond the boundaries of the current state-of-the-art in drug delivery with lipid nanoparticles (LNPs), focusing on ionizable lipids and refined formulations. These accomplishments will not only improve delivery efficiency, but also enable precise targeting for enhanced therapeutic outcomes.
Discover some of our projects
